Chang Gong - Concepedia

Author

Chang Gong

Sun Yat-sen University ORCID

Also Known As

C Gong, C. Gong, CHANG GONG, Caichun Gong, Chang Gong, Chang Gong*, Cheng Bing Gong, Cheng Gong, Chuxiong Gong, Gong C

116

Publications

7.8K

Citations

H-Index

Concepts

All Affiliations

Sun Yat-sen University Sun Yat-sen Memorial Hospital Sun Yat-sen University Cancer Center Guangzhou Medical University Inserm

About

Chang Gong is an author at Sun Yat-sen University specializing in tumor biology, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	4.8K
2	Health Sciences	1	1	45
3	Social Sciences	1	1	69
4	Biochemistry	1	1	65
5	Biostatistics	1	1	20

Chang Gong

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells Fengyan Yu, Herui Yao, Pengcheng Zhu, Cell Breast OncologyOncologyCell RegulationMedicineBreast Cancer Cells	2007	1.9K
A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis Bodu Liu, Lijuan Sun, Qiang Liu, Cancer Cell Transcriptional RegulationBreast OncologyMedicineCancer Cell BiologyLong Non-coding Rna	2015	945
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3 Jingqi Chen, Yandan Yao, Chang Gong, Cancer Cell Breast OncologyMedicineImmunologyCancer Cell BiologyBreast Cancer	2011	649
Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like/progenitor cells Chang Gong, Chantal Bauvy, Giovanni Tonelli, Oncogene	2012	374
Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p Zihao Liu, You Zhou, Gehao Liang, Cell Death and Disease	2019	344
Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer Chang Gong, Yandan Yao, Ying Wang, Journal of Biological Chemistry Trastuzumab ResistanceBreast OncologyMedicinePten ExpressionImmunology	2011	306
Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression Gehao Liang, Yun Ling, Maryam Mehrpour, Molecular Cancer	2020	263
Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5 Yinghua Zhu, Fengyan Yu, Yu Jiao, Clinical Cancer Research	2011	256
Long non‐coding <scp>RNA </scp><i><scp>HOTAIR</scp></i> is an independent prognostic marker for nasopharyngeal carcinoma progression and survival Yan Nie, Xiang Liu, Shaohua Qu, Cancer Science	2013	253
MicroRNAs and cancer: Key paradigms in molecular therapy (Review) Weige Tan, Bodu Liu, Shaohua Qu, Oncology Letters Potential Therapeutic ModalityMolecular TherapyMedicinePathologyCancer Genomics	2017	197

Page 1